Lee Financial CO Dyadic International Inc Transaction History

Lee Financial CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$3.01 - $4.81 $3,010 - $4,810	-1,000 Reduced 25.0%	3,000 $9,000
Q4 2021 Feb 08, 2022	BUY	$3.36 - $5.34 $3,360 - $5,340	1,000 Added 33.33%	4,000 $18,000
Q3 2021 Nov 12, 2021	BUY	$3.3 - $6.49 $9,900 - $19,470	3,000 New	3,000 $16,000
Q1 2021 May 13, 2021	SELL	$4.75 - $6.87 $4,750 - $6,870	-1,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$5.35 - $7.77 $5,350 - $7,770	-1,000 Reduced 50.0%	1,000 $5,000
Q3 2020 Nov 03, 2020	BUY	$7.22 - $9.11 $7,220 - $9,110	1,000 Added 100.0%	2,000 $15,000
Q1 2020 May 07, 2020	SELL	$2.58 - $6.6 $2,580 - $6,600	-1,000 Reduced 50.0%	1,000 $5,000
Q3 2019 Nov 08, 2019	BUY	$4.98 - $6.7 $9,960 - $13,400	2,000 New	2,000 $12,000

4.77M

20.6K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $48.3M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.